Investigating how prenatal exposure to e-cigarette residue affects blood platelets
The Effects of Prenatal Thirdhand E-cigarette Exposure on Platelets
This study is looking at how being around e-cigarette smoke during pregnancy might affect the blood platelets of unborn babies and lead to health problems related to blood clots, helping us understand the risks of e-cigarette use for pregnant people and their babies.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m University Health Science Ctr NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project ID | NIH-10892421 on NIH RePORTER |
What this research studies
This research explores the effects of prenatal exposure to thirdhand e-cigarette smoke on blood platelets and related health issues. It aims to understand how this exposure may contribute to thrombotic diseases, which are conditions related to blood clotting. The study will utilize a novel exposure model to assess the impact of this residue on platelet function and disease development. By examining these effects, the research seeks to provide insights into the health risks associated with e-cigarette use during pregnancy.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who were exposed to e-cigarette residue during pregnancy and are now experiencing health issues related to blood clotting.
Not a fit: Patients who have not been exposed to e-cigarette residue during pregnancy are unlikely to benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and prevention of thrombotic diseases in individuals exposed to e-cigarette residue in utero.
How similar studies have performed: While there is emerging evidence on the health effects of e-cigarettes, this specific investigation into prenatal exposure and its impact on platelets is relatively novel.
Where this research is happening
College Station, United States
- Texas A&m University Health Science Ctr — College Station, United States (Active)
Researchers
- Principal investigator: Khasawneh, Fadi T — Texas A&m University Health Science Ctr
- Study coordinator: Khasawneh, Fadi T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.